Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.99 CHF | +0.52% | +4.12% | +11.92% |
Sales 2024 * | 49.13B 43.71B | Sales 2025 * | 51.26B 45.61B | Capitalization | 217B 193B |
---|---|---|---|---|---|
Net income 2024 * | 10.44B 9.29B | Net income 2025 * | 11.69B 10.4B | EV / Sales 2024 * | 4.67 x |
Net Debt 2024 * | 12.07B 10.74B | Net Debt 2025 * | 10.61B 9.44B | EV / Sales 2025 * | 4.45 x |
P/E ratio 2024 * |
20.8
x | P/E ratio 2025 * |
18
x | Employees | 76,057 |
Yield 2024 * |
3.41% | Yield 2025 * |
3.53% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | +0.52% | ||
1 week | +4.12% | ||
Current month | +1.95% | ||
1 month | +7.82% | ||
3 months | +4.32% | ||
6 months | +11.90% | ||
Current year | +11.92% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 17 M€ | +8.38% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 94.99 | +0.52% | 2,898,671 |
24-06-05 | 94.5 | +1.91% | 3,915,346 |
24-06-04 | 92.73 | 0.00% | 3,103,485 |
24-06-03 | 92.73 | -0.47% | 3,174,216 |
24-05-31 | 93.17 | +2.13% | 10,828,320 |
Delayed Quote Swiss Exchange, June 06, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.92% | 217B | |
+43.64% | 754B | |
+39.42% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
-2.62% | 216B | |
+0.03% | 163B | |
+6.13% | 164B | |
+1.39% | 124B |
- Stock Market
- Equities
- NOVN Stock